Motivating the unmotivated for health behavior change: A randomized trial of cessation induction for smokers

Clinical Trials

Volumn 7, Issue 2, 2010, Pages 157-166

  Carpenter, Matthew J ^a,b   Alberg, Anthony J ^b   Graya, Kevin M ^a   Saladin, Michael E ^a,b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE; NICOTINIC AGENT;

ARTICLE; BEHAVIOR CHANGE; CLINICAL TRIAL; COGNITIVE THERAPY; FOLLOW UP; HEALTH BEHAVIOR; HUMAN; LOZENGE; MAJOR CLINICAL STUDY; MOTIVATION; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SELF CONCEPT; SMOKING CESSATION; TELEHEALTH; TOBACCO DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; TELEPHONE;

HEALTH BEHAVIOR; HUMANS; NICOTINE; NICOTINIC AGONISTS; RESEARCH DESIGN; SMOKING CESSATION; TELEPHONE;

EID: 77953661438     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774510361533     Document Type: Article

References (55)

1. Wewers ME, Stillman FA, Hartman AM, Shopland DR. Distribution of daily smokers by stage of change: Current Population Survey results. Prev Med 2003; 36: 710-20.
2. USDHS. Cigarette smoking among adults\United States 2006. MMWR 2007; 56: 1157-61.
3. Stead LF, Bergson G, Lancaster T. Physician Advice for Smoking Cessation (Cochrane Review). The Cochrane Library Issue 3. Wiley, Oxford, 2008.
4. Fiore MC, Jaén CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. US Public Health Service, Rockville, MD, 2008.
5. Prochaska JO, Redding CA, Evers KE. The transtheore-tical model and stages of change. In Glanz K, RImer B, Lewis F. (eds). Health Behavior and Health Education: Theory, Research, and Practice. Jossey-Bass, San Francisco, 2002, pp. 99-120.
6. Prochaska JO, Velicer WF, Fava JL, et al. Evaluating a population-based recruitment approach and a stage-based expert system intervention for smoking cessation. Addict Behav 2001; 26: 583-602.
7. Prochaska JO, Velicer WF, Fava JL, et al. Counselor and stimulus control enhancements of a stage-matched expert system intervention for smokers in a managed care setting. Prev Med 2001; 32: 23-32.
8. Prochaska JO, Velicer WF, Prochaska JM, Johnson JL. Size, consistency, and stability of stage effects for smoking cessation. Addict Behav 2004; 29: 207-13.
9. Spencer L, Pagell F, Hallion ME, Adams TB. Applying the transtheoretical model to tobacco cessation and prevention: A review of literature. Am J Health Promot 2002; 17: 7-71.
10. Riemsma RP, Pattenden J, Bridle C, et al. Systematic review of the effectiveness of stage based interventions to promote smoking cessation. Br Med J 2003; 326: 1175-81.
11. Bansal MA, Cummings KM, Hyland A, Giovino GA. Stop-smoking medications: Who uses them, who misuses them, and who is misinformed about them? Nicotine Tobacco Res 2004; 6: S303-10.
12. Cummings KM, Hyland A, Giovino GA, et al. Are smokers adequately informed about the health risks of smoking and medicinal nicotine? Nicotine Tobacco Res 2004; 6: S333-40.
13. Mooney ME, Leventhal AM, Hatsukami DK. Attitudes and knowledge about nicotine and nicotine replacement therapy. Nicotine Tobacco Res 2006; 8: 435-46.
14. Pederson LL, Nelson D. Literature review and summary of perceptions, attitudes, beliefs, and marketing of potentially reduced exposure products: Communication implications. Nicotine Tobacco Res 2007; 9: 525-34.
15. Vogt F, Hall S, Marteau TM. Understanding why smokers do not want to use nicotine dependence medications to stop smoking: Qualitative and quantita-tive studies. Nicotine Tobacco Res 2008; 10: 1405-13.
16. Cokkinides VE, Ward E, Jemal A, Thun MJ. Under-use of smoking-cessation treatments: Results from the National Health Interview Survey, 2000. Am J Prev Med 2005; 28: 119-22.
17. Shiffman S, Brockwell SE, Pillitteri JL, Gitchell JG Use of smoking-cessation treatments in the United States. Am JPrev Med 2008; 34: 102-11.
18. Alberg AJ, Margalit RS, Burke A, et al. The influence of offering free transdermal nicotine patches on quit rates in a local health department's smoking cessation pro-gram. Addict Behav 2004; 29: 1763-78.
19. Jolicoeur DG, Ahluwalia JS, Richter KP, et al. The use of nicotine patches with minimal intervention. Prev Med 2000; 30: 504-12.
20. Jolicoeur DG, Richter KP, Ahluwalia JS, et al. Smoking cessation, smoking reduction, and delayed quitting among smokers given nicotine patches and a self-help pamphlet. Substance Abuse 2003; 24: 101-06.
21. Fellows JL, Bush T, McAfee T, et al. Cost effectiveness of the Oregon quitline "free patch initiative". Tobacco Control 2007; 16: i47-52.
22. Bush TM, McAfee T, Deprey M, et al. The impact of a free nicotine patch starter kit on quit rates in a state quit line. Nicotine Tobacco Res 2008; 10: 1511-16.
23. Miller N, Frieden TR, Liu SY, et al. Effectiveness of a large-scale distribution programme of free nicotine patches: A prospective evaluation. Lancet, 2005; 365: 1849-54.
24. Schneider NG, Justice M, Gould JL, et al. Preferences among five nicotine treatments based on information versus sampling. Nicotine Tobacco Res 2008; 10: 179-86.
25. Perkins KA, Stitzer M, Lerman C. Medication screening for smoking cessation: Proposal for new technologies. Psychopharmacology 2006; 184: 628-36.
26. Brown RA, Lejuez CW, Kahler CW, et al. Distress tolerance and early smoking lapse. Clin Psychol Rev 2005; 25: 713-33.
27. Salkovskis P. The importance of behavior in the main-tenance of anxiety and panic: A cognitive account. Behav Psychother 1991; 19: 6-19.
28. Bennett-Levy J, Butler G, Fennell M, et al. Oxford Guide to Behavioral Experiments in Cognitive Therapy. Oxford University Press, Oxford, England, 2004.
29. Heil SH, Alessi SM, Lussier JP, et al. An experimental test of the influence of prior cigarette smoking abstinence on future abstinence. Nicotine Tobacco Res 2004; 6: 471-9.
30. Paul CL, Wiggers J, Daly JB, et al. Direct telemarketing of smoking cessation interventions: Will smokers take the call? Addiction 2004; 99: 907-13.
31. Carpenter MJ, Hughes JR, Keely JP. Effects of smoking reduction on later cessation: A pilot experimental study. Nicotine Tobacco Res 2003; 5: 155-62.
32. Carpenter MJ, Hughes JR, Solomon LJ, Callas PW. Both smoking reduction with nicotine replacement therapy and motivational advice increase future cessation among smokers unmotivated to quit. J Consult Clin Psychol 2004; 72: 371-81.
33. USDHS, Cigarette smoking among adults-United States 2003. MMWR 2005; 54: 509-13.
34. Solomon LJ, Scharoun GM, Flynn BS, et al. Free nicotine patches plus proactive telephone peer support to help low-income women stop smoking. Prev Med 2000; 31: 68-74.
35. Solomon LJ, Secker-Walker RH, Flynn BS, et al. Proactive telephone peer support to help pregnant women stop smoking. Tob Control 2000; 9: 72.
36. Carpenter MJ, Strange C, Jones Y, et al. Does genetic testing result in behavioral health change? Changes in smoking behavior following testing for Alpha-1 Antitrypsin Deficiency. Ann Behav Med 2007; 33: 22-8.
37. Hughes JR. Motivating and helping smokers to stop smoking. J Gen Intern Med 2003; 18: 1053-57.
38. Velicer WF, Diclemente CC, Rossi JS, Prochaska JO. Relapse situations and self-efficacy: An integrative model. Addict Behav 1990; 15: 271-83.
39. Etter JF, Perneger TV. Pharmacoepidemiology and drug utilization: Attitudes toward nicotine replacement ther-apy in smokers and ex-smokers in the general public. Clin Pharmacol Ther 2001; 69: 175-83.
40. Park E-W, Tudiver F, Schultz JK, Campbell T. Does enhancing partner support and interaction improve smoking cessation? A meta-analysis. Ann Fam Med 2004; 2: 170-74.
41. Hughes JR, Gust SW, Skoog K, et al. Symptoms of tobacco withdrawal: A replication and extension. Arch Gen Psychiatry 1991; 48: 52-9.
42. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 1986; 43: 289-94.
43. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73: 13-22.
44. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Nicotine Dependence. American Psychiatric Association, Washington DC, 1996.
45. Kreuter MW, Chheda SG, Bull FC. How does physician advice influence patient behavior? Evidence for a prim-ing effect. Arch Fam Med 2000; 9: 426-33.
46. West R, McEwen A, Bolling K, Owen L. Smoking cessation and smoking patterns in the general popula-tion: A 1-year follow-up. Addiction 2001; 96: 891-902
47. USDHS, Cigarette smoking among adults\United States, 2007 MMWR, 2008; 57; 1221-6.
48. Carpenter MJ, Hughes JR. Defining quit attempts: What difference does a day make? Addiction 2005; 100: 257-8.
49. Benowitz N, Ahijevych K, Hall S, et al. Biochemical verification of tobacco use and cessation. Nicotine Tobacco Res 2002; 4: 149-59.
50. Hughes JR, et al. Measures of abstinence in clinical trials: Issues and recommendations. Nicotine Tobacco Res 2003; 5: 13-25.
51. Hughes JR, Giovino GA, Kelvins RM, Fiore MC. Assessing the generalizability of smoking studies. Addiction 1997; 92: 469-472.
52. Etter JF, Perneger TV. A comparison of cigarette smokers recruited through the internet or by mail. Int J Epidemiol 2001; 30: 521-25.
53. Etter JF. The internet and the industrial revolution in smoking cessation counselling. Drug Alcohol Rev 2006; 25: 79-84.
54. Walters ST, Wright JA, Shegog R. A review of computer and Internet-based interventions for smoking behavior. Addict Behav 2006; 31: 264-77.
55. West R, Gilsenan A, Coste F, et al. The ATTEMPT cohort: A multi-national longitudinal study of predictors, patterns and consequences of smoking cessation; introduction and evaluation of internet recrunitment and data collec-tion methods. Addiction 2006; 101: 1352-61.